Alexandria Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $404K | Buy |
3,568
+280
| +9% | +$31.7K | 0.04% | 195 |
|
|
2021
Q2 | $341K | Hold |
3,288
| – | – | 0.03% | 211 |
|
|
2021
Q1 | $275K | Hold |
3,288
| – | – | 0.03% | 229 |
|
|
2020
Q4 | $300K | Sell |
3,288
-15
| -0.5% | -$1.37K | 0.03% | 213 |
|
|
2020
Q3 | $264K | Hold |
3,303
| – | – | 0.03% | 215 |
|
|
2020
Q2 | $228K | Hold |
3,303
| – | – | 0.03% | 220 |
|
|
2020
Q1 | $208K | Buy |
3,303
+15
| +0.5% | +$945 | 0.03% | 212 |
|
|
2019
Q4 | $256K | Hold |
3,288
| – | – | 0.03% | 224 |
|
|
2019
Q3 | $241K | Sell |
3,288
-96
| -3% | -$7.04K | 0.04% | 219 |
|
|
2019
Q2 | $208K | Buy |
3,384
+96
| +3% | +$5.9K | 0.03% | 250 |
|
|
2019
Q1 | $210K | Buy |
+3,288
| New | +$210K | 0.03% | 247 |
|
|
2018
Q4 | – | Sell |
-3,477
| Closed | -$202K | – | 253 |
|
|
2018
Q3 | $202K | Buy |
+3,477
| New | +$202K | 0.03% | 226 |
|
|
2017
Q4 | – | Sell |
-3,498
| Closed | -$127K | – | 332 |
|
|
2017
Q3 | $127K | Buy |
3,498
+60
| +2% | +$2.18K | 0.03% | 163 |
|
|
2017
Q2 | $136K | Buy |
3,438
+57
| +2% | +$2.26K | 0.03% | 158 |
|
|
2017
Q1 | $106K | Buy |
3,381
+3
| +0.1% | +$94 | 0.03% | 174 |
|
|
2016
Q4 | $106K | Buy |
3,378
+90
| +3% | +$2.82K | 0.03% | 168 |
|
|
2016
Q3 | $132K | Sell |
3,288
-1,644
| -33% | -$66K | 0.02% | 171 |
|
|
2016
Q2 | $164K | Buy |
4,932
+1,644
| +50% | +$54.7K | 0.03% | 152 |
|
|
2016
Q1 | $97K | Buy |
3,288
+1,644
| +100% | +$48.5K | 0.02% | 191 |
|
|
2015
Q4 | $43K | Buy |
+1,644
| New | +$43K | 0.01% | 273 |
|
|
2015
Q2 | – | Sell |
-720
| Closed | -$17K | – | 613 |
|
|
2015
Q1 | $17K | Buy |
+720
| New | +$17K | 0.01% | 327 |
|
|
2014
Q2 | – | Sell |
-720
| Closed | -$9K | – | 589 |
|
|
2014
Q1 | $9K | Hold |
720
| – | – | ﹤0.01% | 368 |
|
|
2013
Q4 | $8K | Hold |
720
| – | – | ﹤0.01% | 385 |
|
|
2013
Q3 | $8K | Hold |
720
| – | – | ﹤0.01% | 387 |
|
|
2013
Q2 | $8K | Buy |
+720
| New | +$8K | ﹤0.01% | 404 |
|